Gimsilumab Antibody
Gimsilumab (MORAb-022) is a humanized monoclonal antibody designed to neutralize granulocyte-macrophage colony-stimulating factor (GM-CSF) . It is intended for research into the hyperinflammatory response and acute respiratory distress associated with severe COVID-19, with studies exploring its potential in both in vitro and in vivo models of cytokine-driven pathology.
Product Specifications
Product Name Alternative
MORAb-022, KIN-1901, cFms, c-Fms, SARSCoV, SARS-CoV
Target
C-Fms, SARS-CoV
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology, Signal Transduction
Concentration
2.95 mg/mL
Purity
99.49% (May vary between batches)
Molecular Weight
145.8 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Anti-MPI Antibody Picoband® (monoclonal, 11I4) (Biotine Conjugate)
SNRPC (Small Nuclear Ribonucleoprotein Polypeptide C, SNRP-C)